Here Tuesday’s the biggest calls on Wall Street:
The firm said it’s sticking with the stock following a meeting with Nvidia management at the JPMorgan healthcare conference.
“The healthcare vertical business is estimated to drive $1B+ of annual recurring revenues in FY26, making it one of the top vertical market segments within Nvidia’s datacenter business.”
Wells Fargo said it’s bullish on the stock ahead of earnings later this month.
“From our recent field work, we’re expecting a balanced FQ2 w/o any major surprises from MSFT. See any clearing of AI capacity debate (& clarity on Azure re-accel) as likely to unlock more significant 2H upside. Reiterate OW & $515 PT.”
The firm raised its price target on the stock to $225 per share from $210.
“With search still far overshadowing value of other businesses, we view 2025 as a pivotal year, which could help establish Google as either an Al leader (via AI Overview traction) or see elevation in search disruption risk.”
Goldman said it likes Meta ahead of earnings later this month.
“We believe META mgmt remains focused on long-term opportunities (artificial intelligence & Reality Labs), with an increased focus on aligning investments across a world-class compute infrastructure, open-source software initiatives and a raised range of forward capex.”
Wells said it’s standing by the stock ahead of earnings next week.
“We think NFLX could beat on Q4 subs, but upward ’25 revisions could be constrained by the stronger USD + investing in the ad strategy. The stock has rerated to 35x P/E on sports/live. We like the long term, but we’re less favorable on the setup.”
The firm raised its price target on the stock to $715 per share from $550.
“Netflix’s premium valuation is predicated on revenue growth being at least in the low double digit range.”
Loop said the stock has “dominant revenue exposure to mature end markets.”
“We are initiating coverage of AMD with a Buy rating and $175 tgt.”
The firm said it prefers Visa over Mastercard due to U.S. exposure.
“We’ve upgraded Visa to Buy from Neutral – this year, we prefer it on a relative basis over Mastercard (downgrading Mastercard to Neutral from Buy). This is primarily due to Visa’s more significant US exposure (a key theme of ours in ’25) - we expect upside vs. consensus revenue/EPS for Visa this year.”
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.